Skip to content. | Skip to navigation

Personal tools


  • Diaz VM, Planaguma J, Thomson TM, Reventos J, Paciucci R. Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells. Gastroenterology vol. 122, 806-819 (2003).
  • Diaz VM, Hurtado M; Thomson TM, Reventos J, Paciucci R. Specific interaction of tissue-type plasminogen activator (t-PA) with annexin II on the membrane of pancreatic cancer cells activates plasminogen and promotes invasion in vitro. Gut vol. 53,  993 – 1000 (2004).
  • Diaz VM, Hurtado M, Kort EJ, Resnati M, Blasi F, Thomson T, Paciucci R. Requirement of the enzymatic and signaling activities of plasmin for phorbol-ester-induced scattering of colon cancer cells. Experimental Cell Research vol. 312, 2203 – 2213 (2006).
  • Ferrer B, Bermudo R, Thomson T, Nayach I, Soler M, Sanchez M, Castillo M, Calvo J, Campo E, Fernandez PL. Paraffin-embedded cell line microarray (PECLIMA): Development and validation of a high-throughput method for antigen profiling of cell lines. Pathobiology vol. 72, 225  -  232 (2005).
  • Lozano JJ, Soler M, Bermudo R, Abia D, Fernandez PL, Thomson TM, Ortiz AR. Dual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by Factor Analysis of microarray data. BMC Genomics vol. 6, 1  -  18 (2005).
  • Plans V, Scheper J, Soler M, Loukili N, Okano Y, Thomson TM. The RING finger protein RNF8 recruits UBC13 for lysine 63-based self polyubiquitylation. J Cell Biochem vol. 97, 572 – 582 (2006).
  • Kolas NK, Chapman JR, Nakada S, Ylanko J, Chahwan R, Sweeney FD, Panier S, Mendez M, Wildenhain J, Thomson TM, Pelletier L, Jackson SP, Durocher D. Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase. Science vol. 318, 1637 – 1640 (2007).
  • Plans V, Guerra-Rebollo M, Thomson TM (2008). Regulation of mitotic exit by the RNF8 ubiquitin ligase. Oncogene vol. 27, 1355 - 1365 (2008).
  • Scheper J, Oliva B, Villà-Freixa J, Thomson TM. Analysis of electrostatic contributions to the selectivity of interactions between RING-finger domains and ubiquitin-conjugating enzymes. Proteins vol. 74, 92 - 103 (2008).
  • Bermudo R, Abia D, Ferrer B, Nayach I, Benguria A, Zaballos A, del Rey J, Miró R, Campo E, Martínez-A C, Ortiz AR, Fernández PL, Thomson TM. Co-regulation analysis of closely linked genes identifies a highly recurrent gain on chromosome 17q25.3 in prostate cancer. BMC Cancer vol. 8, 315 (2008).
  • Soler M, Mancini F, Meca-Cortés O, Sánchez-Cid L, Rubio N, López-Fernández S, Lozano JJ, Blanco J, Fernández PL, Thomson TM. HER3 is required for the maintenance of neuregulin-dependent and –independent attributes of malignant progression in prostate cancer. Int J Cancer vol. 125, 2565-2575 (2009).
  • Crosas B, Farràs R, Marfany G, Rodríguez MS, Thomson TM. Searching for the boundaries: unlimited expansion of ubiquitin and ubiquitin-like signals in multiple cellular functions. Biochem Soc Trans vol. 38 (Pt 1), 1-5 (2010).
  • Thomson TM, Guerra-Rebollo M. Ubiquitin and SUMO signaling in DNA Repair. Biochem Soc Trans vol. 38 (Pt 1), 116-131 (2010).
  • Isasa M, Katz E, Kim W, Yugo V, González S, Kirkpatrick DS, Thomson TM, Finley D, Gygi SP, Crosas B. Monoubiquitination of Rpn10 regulates substrate recruitment to the proteasome. Mol Cell vol. 38(5), 733-45 (2010).
  • Gómez V, Sesé M, Santamaría A, Martínez JD, Castellanos E, Soler M, Thomson TM, Paciucci R. Regulation of Aurora B kinase by the lipid raft protein Flotillin-1.J Biol Chem 285(27), 20683-90 (2010).
  • Scheper J, Guerra-Rebollo M, Moure A, Masip I, González-Ruiz D, Rubio N, Crosas B, Meca-Cortés O, Loukili N, Plans V, Morreale A, Blanco J, Ortiz AR, Messeguer A, Thomson TM. Protein-protein interaction antatonists as novel inhibitors of non-canonical polyubiquitylation. PLOS One vol. 5(6), e11403 (2010).
  • Bermudo R, Abia D, Benítez D, Carrió A, Vilella R, Ortiz AR, Thomson TM, Fernández PL. discovery of genomic alterations through coregulation analysis of closely linked genes: a frequent gain in 17q25.3 in prostate cancer. Ann NY Acad Sci vol. 210 (1), 17-24 (2010).
  • Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celià-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y, Wei Y, Hu G, Garcia BA, Ragoussis J, Amadori D, Harris AL, Kang Y. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med vol. 17(9), 1101-8 (2011).
  • Lok GT, Sy SM, Dong SS, Ching YP, Tsao SW, Thomson TM, Huen MS. Differential regulation of RNF8-mediated Lys48- and Lys63-based poly-ubiquitylation. Nucleic Acids Res vol. 40 (1), 196-205 (2011).
  • Bermudo R, Abia D, Mozos A, García E, Alcaraz A, Ortiz AR, Thomson TM, Fernández PL. Highly sensitive molecular diagnosis of prostate cancer using surplus material washed off from biopsy needles. Br J Cancer vol. 105 (10), 1600-7 (2011).
  • Celià-Terrassa T, Meca-Cortés O, Mateo F, Martínez de Paz A, Rubio N, Arnal-Estapé A, Ell BJ, Bermudo R, Díaz A, Guerra-Rebollo M, Lozano JJ, Estarás C, Ulloa C, Álvarez-Simón D, Milà J, Vilella R, Paciucci R, Martínez-Balbás M, García de Herreros A, Gomis RR, Kang Y, Blanco J, Fernández PL, Thomson TM. Epithelial-mesenchymal transition can suppress major attributes of epitelial tumor-initiating cells. J Clin Invest 122(5), 1849-1868 (2012).
  • Guerra-Rebollo M, Mateo F, Franke K, Huen MSY, Lopitz-Otsoa F, Rodríguez MS, Plans V, Thomson TM. Nucleolar exit of RNF8 and BRCA1 in response to DNA damage. Exp Cell Res 318(18), 2365-76 (2012).
  • Zhang S, Zhou Y, Sarkeshik A, Yates J, Thomson TM, Zhang Z, Lee EY, Lee MY. Identification of RNF8 as a ubiquitin ligase involved in targeting the p12 subunit of DNA polymerase δ for degradation in response to DNA damage. J Biol Chem 288(5), 2941-50 (2013).
  • Marqués M, Cánovas V, Sesé M, Valente F, Bermudo R, Torres I, Fernández Y, Abasolo I, Fernández PL, Contreras H, Castellón E, Celià-Terrassa T, Méndez R, Ramón y Cajal S, Thomson TM, Paciucci R. Regulation of protein translation and c-Jun expression by Prostate Tumor Overexpressed 1 (PTOV1). Oncogene (in press) (2013).
  • Camacho L, Meca-Cortes O, Abad JL, Garcia S, Rubio N, Diaz A, Celia-Terrassa T, Cingolani F, Bermudo R, Fernandez PL, Blanco J, Delgado A, Casas J, Fabrias G, Thomson TM. Acid ceramidase as a therapeutic target in metastatic prostate cancer. J Lipid Res (in press) (2013).
  • Mateo F, Fernández PL, Thomson TM. Stem cells in prostate cancer. Arch Esp Urol (in press) (2013).

Document Actions